Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease

Journal of Hepatology

Volumn 40, Issue 3, 2004, Pages 409-416

  Klein, Dominik ^a,b   Arora, Uma ^b   Lichtmannegger, Josef ^b   Finckh, Matthias ^b   Heinzmann, Ulrich ^b   Summer, Karl H ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Ammonium tetrathiomolybdate; Copper toxicity; Hepatitis; Iron overload; Long Evans Cinnamon rat; Therapy; Wilson disease

Indexed keywords

CHELATING AGENT; COPPER; IRON; METALLOTHIONEIN; POLYMER; TETRATHIOMOLYBDIC ACID;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DYING; FATALITY; FEMALE; INTOXICATION; LIVER TOXICITY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; RAT; WILSON DISEASE;

EID: 1242292347     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.11.034     Document Type: Article

References (49)

1. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The WiIson disease gene is a putative copper transporting P-type ATPase simiIar to the Menkes gene. Nat Genet. 5:1993;327-337.
2. Tanzi R.E., Petrukhin K., Chernow I., Pellequer J.L., Wasco W., Ross B., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 5:1993;344-350.
3. Brewer G.W., Yuzbasiyan-Gurkan V. Wilson disease. Medicine. 71:1992;139-164.
4. Scheinberg I.H., Sternlieb I. Wilson's disease. Smith L.H. Jr. Major problems in internal medicine. 1984;1-171 WB Saunders, Philadelphia, PA.
5. Li Y., Togashi Y., Sato S., Emoto T., Kang J.H., Takeichi N., et al. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. J Clin Invest. 87:1991;1858-1861.
6. Schilsky M.L., Stockert R.J., Sternlieb I. Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. Am J Physiol. 266:1994;G907-G913.
7. Suzuki M., Aoki T. Impaired hepatic copper homeostasis in Long-Evans Cinnamon rats: reduced biliary excretion of copper. Pediatr Res. 35:1994;598-601.
8. Yamada T., Agui T., Suzuki Y., Sato M., Matsumoto K. Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans Cinnamon mutant rats. J Biol Chem. 268:1993;8965-8971.
9. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 7:1994;541-545.
10. Yamaguchi Y., Heiny M.E., Shimizu N., Aoki T., Gitlin J.D. Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. Biochem J. 301:1994;1-4.
11. Mori M., Hattori A., Sawaki M., Tsuzuki N., Sawada N., Oyamada M., et al. The LEC rat: a model for human hepatitis, liver cancer, and much more. Am J Pathol. 144:1994;200-204.
12. Kato J., Kohgo Y., Sugawara N., Katsuki S., Shintani N., Fujikawa K., et al. Abnormal hepatic iron accumulation in LEC rats. Jpn J Cancer Res. 84:1993;219-222.
13. Kato J., Kobune M., Kohgo Y., Sugawara N., Hisai H., Nakamura T., et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans cinnamon rats. J Clin Invest. 98:1996;923-929.
14. Luca P., Demelia L., Lecca S., Ambu R., Faa G. Massive hepatic hemosiderosis in Wilson's disease. Histopathology. 37:2000;187-189.
15. Shiono Y., Hayashi H., Wakusawa S., Yano M. Ultrastructural identification of iron and copper accumulation in the liver of a male patient with Wilson disease. Med Electron Microsc. 34:2001;54-60.
16. Ma Y., Zhang D., Kawabata T., Kiriu T., Toyokuni S., Uchida K., Okada S. Copper and iron-induced oxidative damage in non-tumor bearing LEC rats. Pathol Int. 47:1997;203-208.
17. Brewer G.J. Raulin Award Lecture: Wilson's disease therapy with zinc and tetrathiomolybdate. J Trace Elem Exp Med. 13:2000;51-61.
18. Brewer G.J. Wilson's disease: a clinician's guide to recognition, diagnosis, and management. 2001;Kluwer, Boston, MA.
19. Roberts E.A., Schilsky M.L. A practice guideline on Wilson disease. Hepatology. 37:2003;1475-1492.
20. Brewer G.J., Terry C.A., Aisen A.M., Hill G.M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 44:1987;490-494.
21. Brewer G.J., Dick R.D., Yuzbasiyan-Gurkan V., Tanakow R., Young A.B., Kluin K.J. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol. 48:1991;42-47.
22. Brewer G.J., Dick R.D., Johnson V., Wang Y., Yuzbasiyan-Gurkan V., Kluin K., et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol. 51:1994;545-554.
23. Brewer G.J., Johnson V., Dick R.D., Kluin K.J., Fink J.K., Brunberg J.A. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 53:1996;1017-1025.
24. Klein D., Lichtmannegger J., Heinzmann U., Müller-Höcker J., Michaelsen S., Summer K.H. Association of copper to metallothionein in hepatic lysosomes of Long-Evans Cinnamon (LEC) rats during the development of hepatitis. Eur J Clin Invest. 28:1998;302-310.
25. Klein D., Lichtmannegger J., Heinzmann U., Summer K.H. Dissolution of copper-rich granules in hepatic lysosomes by D-penicillamine prevents the development of fulminant hepatitis in Long-Evans Cinnamon rats. J Hepatol. 32:2000;193-201.
26. Presta A., Green A.R., Zelazowski A., Stillman M.J. Copper binding to rabbit liver metallothionein. Formation of a continuum of copper(I)-thiolate stoichiometric species. Eur J Biochem. 227:1995;226-240.
27. Klein D., Bartsch R., Summer K.H. Quantitation of Cu-containing metallothionein by a Cd-saturation method. Anal Biochem. 189:1990;35-39.
28. Yamada T., Agui T., Suzuki Y., Sato M., Matsumoto K. Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans Cinnamon mutant rat. J Biol Chem. 268:1993;8965-8971.
29. Vielhauer W., Eckardt V., Holtermuller K.H., Luth J.B., Schulte B., Prellwitz W., Sonntag W. D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis. Dig Dis Sci. 27:1982;1126-1129.
30. Schilsky M.L., Scheinberg I.H., Sternlieb I. Liver transplantation for Wilson's disease: indication and outcome. Hepatology. 19:1994;583-587.
31. Gooneratne S.R., Howell J.M., Gawthorne J.M. An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep. Br J Nutr. 46:1981;469-480.
32. Suzuki K.T., Yamamoto K., Kanno S., Aoki Y., Takeichi N. Selective removal of copper bound to metallothionein in the liver of LEC rats by tetrathiomolybdate. Toxicology. 83:1993;149-158.
33. Suzuki K.T., Ogra Y., Ohmichi M. Molybdenum and copper kinetics after tetrathiomolybdate injection in LEC rats: specific role of serum albumin. J Trace Elem Med Biol. 9:1995;170-175.
34. Brewer G.J. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease. Nutrition. 11:1995;114-116.
35. Komatsu Y., Sadakata I., Ogra Y., Suzuki K.T. Excretion of copper complexed with thiomolybdate into the bile and blood in LEC rats. Chem Biol Interact. 124:2000;217-231.
36. Sugawara N., Ikeda T., Lai Y.R., Sugawara C. The effect of subcutaneous tetrathiomolybdate administration on copper and iron metabolism, including their regional redistribution in the brain, in the Long-Evans Cinnamon rat, a bona fide animal model for Wilson's disease. Pharmacol Toxicol. 84:1999;211-217.
37. Suzuki K.T., Ogra Y. Formation of copper-metallothionein/ tetrathiomolybdate complex is the first step in removal of Cu from LEC rats. Res Commun Mol Pathol Pharmacol. 88:1995;187-195.
38. Klaassen C.D., Choudhuri S., McKim J.M. Jr., Lehman-McKeeman L.D., Kershaw W.C. In vitro and in vivo studies on the degradation of metallothionein. Environ Health Perspect. 102:1994;141-146.
39. Suzuki K.T., Rui M., Ueda J., Ozawa T. Production of hydroxyl radicals by copper-containing metallothionein: roles as prooxidant. Toxicol Appl Pharmacol. 141:1996;231-237.
40. Shishido N., Nakayama K., Takazawa A., Ohyama T., Nakamura M. Cu-metallothioneins (Cu(I)8-MTs) in LEC rat livers 13 weeks after birth still act as antioxidants. Arch Biochem Biophys. 387:2001;216-222.
41. Abe S., Yamazaki K., Takikawa S., Suzuki K. Impaired biliary excretion of copper and lysosomal enzymes in Long-Evans Cinnamon. Tohoku J Exp Med. 172:1994;355-367.
42. George G.N., Pickering I.J., Harris H.H., Gailer J., Klein D., Lichtmannegger J., Summer K.H. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease. J Am Chem Soc. 125:2003;1704-1705.
43. Sugawara N., Sugawara C., Sato M., Katakura M., Takahashi H., Mori M. Copper metabolism in LEC rats aged 30 and 80 day old: Induction of Cu-metallothionein and status of zinc and iron. Res Commun Chem Pathol Pharmacol. 72:1991;353-362.
44. Kato J., Kobune M., Kohgo Y., Sugawara N., Hisai H., Nakamura T., et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest. 98:1996;923-929.
45. Anderson G.J., Frazer D.M., McKie A.T., Vulpe C.D. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol Dis. 29:2002;367-375.
46. Hamada J., Kobayashi N., Kashiwazaki H., Tonoki H., Moriuchi T. Selenium deficiency does not promote acute hepatitis in Long-Evans Cinnamon (LEC) rats. J Trace Elem Exp Med. 10:1997;119-128.
47. Yamamoto H., Watanabe T., Mizuno H., Endo K., Fukushige J., Hosokawa T., et al. The antioxidant effect of DL-alpha-lipoic acid on copper-induced acute hepatitis in Long-Evans Cinnamon (LEC) rats. Free Radic Res. 34:2001;69-80.
48. Ogra Y., Ohmichi M., Suzuki K.T. Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats. Toxicology. 106:1996;75-83.
49. Ogra Y., Komada Y., Suzuki K.T. Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper. J Inorg Biochem. 75:1999;199-204.